SCHEMBL17631923

SCHEMBL17631923

N#CN(C(=O)[C@H]1CCNC1)c1ncc(Cc2ccccc2)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.50
▸ POLB P06746 1/20 0.40
▸ NPC1 O15118 5/20 0.39
▸ RAB9A P51151 5/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ TP53 P04637 3/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ LMNA P02545 3/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17632036 0.82 USP30 (0.50) UCHL1CHEK1KCNH2USP30
SCHEMBL17632525 0.79 CHEK1 (0.41) UCHL1CHEK1KCNH2USP30
SCHEMBL17631689 0.79 SMN1; SMN2 (0.35) RAB9ASMN1; SMN2KMT2ACHEK1MEN1
SCHEMBL17631706 0.78 GAA (0.36) UCHL1NPC1SMN1; SMN2CYP1A2KMT2A
SCHEMBL17631780 0.78 USP30 (0.39) UCHL1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL17631555 0.77 USP30 (0.33) UCHL1RIPK1USP30
SCHEMBL17632937 0.77 CHEK1 (0.37) UCHL1CHEK1ABL1USP30
SCHEMBL17631847 0.77 USP30 (0.37) UCHL1CHEK1KCNH2USP30
SCHEMBL17632104 0.76 SLC6A2 (0.33) —
SCHEMBL17632081 0.76 KCNH2 (0.38) UCHL1NPC1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP claimed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO claimed
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP disclosed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO disclosed
Send feedback